GLP1R and type 2 diabetes mellitus: The objectives of this study were to evaluate GLP-1 RA uptake among a commercially insured population of patients with T2D; identify associations of race, ethnicity, sex, and socioeconomic status with GLP-1 RA use; and specifically examine GLP-1 RA use among the subgroup of patients with ASCVD because of its known benefit for this population.